IDEX IDEX BIOMETRICS ASA

IDEX Biometrics ASA: First half 2025 report

IDEX Biometrics ASA: First half 2025 report

IDEX Biometrics ASA's first half 2025 report is attached to this notice.

Recent highlights:

  • Operating expenses excluding Cost of materials and Depreciation in the first six months of 2025 amounted to $5.2 million (excluding restructuring cost) compared to $10.7 million for the same period in 2024, resulting in a cost reduction of 52%, year-over-year
  • At the end of the second quarter of 2025 the Company had 30 full-time equivalent staff members, a reduction of 10 full-time equivalents compared to previous quarter, and down from 59 on June 30, 2024. Resulted in a cost reduction in compensation and benefits of $1.9 million, 73%, compared to previous quarter, and a cost reduction of $4.1 million, 72%, year-over-year.
  • Heights convertible bond renegotiated and amended
    • Outstanding principal reduced from approx. NOK66.6 million to approx. NOK50.0 million. In July, further reduced to approx. NOK33.3 million
  • Range of operational improvement initiatives being implemented – target quarterly run rate OPEX from end Q3 2025 in the range of $1.5-1.7 million
  • On June 1, 2025 IDEX strengthened its management team further. Kjell-Arne Besseberg started as IDEX Chief Operating Officer based in our offices in Oslo
  • On June 15, 2025 employees, directors and consultants subscribed for 299,381,600 shares, totaling approximately NOK 3.0 million. Further strengthening the alignment of interest within the company
  • On June 30, 2025, the CEO Anders Storbråten also assumed the role as CFO after Kristian Flaaten. Consolidating the two roles will reduce cost, increase focus and strengthen IDEX investor relations further

Financial results Q2 2025:

  • Revenues of $0.1 million in the quarter
  • Operating expenses were $2.6 million (excluding restructuring cost)
  • Net loss was $2.1 million
  • Cash balance per 30 June 2025 at $1.0 million



IDEX Biometrics’ reports and presentations are available on our website:



For further information, please contact:

Anders Storbråten, CEO and CFO, Tel: +47 416 38 582

E-mail: 



About IDEX Biometrics:

IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market. For more information, visit 



About this notice:

This notice was issued by Kjell-Arne Besseberg, COO, on 27 August 2025 at 07:00 CEST on behalf of IDEX Biometrics ASA. This information is subject to the disclosure requirements pursuant to the Norwegian Securities Trading Act section 5-12.

Attachment



EN
27/08/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IDEX BIOMETRICS ASA

 PRESS RELEASE

Mandatory notice of shareholding 27 August 2025

Mandatory notice of shareholding 27 August 2025 Reference is made to IDEX Biometrics ASA’s disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share. The Tranche 2 shares subscription andallocation have been completed on 20 August 2025. Altea AS will hold 5,347,321 shares in IDEX. The ownership will represent 9,40% of the shares and voting rights in IDEX. Sundt AS will hold 2,804,915 shares in IDEX. The ownership will represent 4,93% of the shares and voting rights in IDEX. About this notice: The information shall be disclosed according to section...

 PRESS RELEASE

IDEX Biometrics ASA: First half 2025 report

IDEX Biometrics ASA: First half 2025 report IDEX Biometrics ASA's first half 2025 report is attached to this notice. Recent highlights: Operating expenses excluding Cost of materials and Depreciation in the first six months of 2025 amounted to $5.2 million (excluding restructuring cost) compared to $10.7 million for the same period in 2024, resulting in a cost reduction of 52%, year-over-yearAt the end of the second quarter of 2025 the Company had 30 full-time equivalent staff members, a reduction of 10 full-time equivalents compared to previous quarter, and down from 59 on June 30, 2024....

 PRESS RELEASE

Mandatory disclosure of holding and notice of trade in IDEX Biometrics...

Mandatory disclosure of holding and notice of trade in IDEX Biometrics - 26 August 2025 Reference is made to IDEX Biometrics ASA's disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share. IDEX discloses the following information on behalf of a major shareholder and primary insider. Tranche 2 of the private placement amounted to 4,359,315 shares. All shares was lent, not sold, by CEO and CFO Anders Storbråten. The shares – 4,359,315 – is now returned to Anders Storbråten. Storbråten and close relations hold 11,555,213 shares or 20,3 % shares of the tot...

 PRESS RELEASE

Mandatory disclosure of holding and notice of trade in IDEX Biometrics...

Mandatory disclosure of holding and notice of trade in IDEX Biometrics – 23 August 2025 Reference is made to IDEX Biometrics ASA's disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share, split in two tranches. IDEX discloses the following information on behalf of primary insiders. In tranche 2 of the private placement, including underwriting shares, 4,813, 857 total shares. Pinchcliffe AS, a company closely related to CEO and CFO Anders Storbråten, subscribed to 469,255 shares, ISIN NO0013536078, at NOK 3.30 per share, and Anders Storbråten, CEO and ...

 PRESS RELEASE

Mandatory notice of shareholding 22 August 2025

Mandatory notice of shareholding 22 August 2025 Reference is made to IDEX Biometrics ASA’s disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share. The Tranche 2 shares subscription andallocation have been completed on 20 August 2025. Altea AS will hold 5,347,321 shares in IDEX. The ownership will represent 10,26% of the shares and voting rights in IDEX. About this notice: The information shall be disclosed according to section 4-2 of the Norwegian Securities Trading Act (STA) and published in accordance with section 5-12 of the STA.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch